Belite Bio Stock (NASDAQ: BLTE) stock price, news, charts, stock research, profile.
Open | $48.50 |
Close | $48.44 |
Volume / Avg. | 27.76K / 39.34K |
Day Range | $47.70 - $48.50 |
52 Wk Range | 28.51 - 50.66 |
Market Cap | $1.43B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 2.28% |
Days to Cover | 15.3 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Belite Bio (NASDAQ:BLTE) through any online brokerage.
Other companies in Belite Bio’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS), Phibro Animal Health (NASDAQ:PAHC) and Neumora Therapeutics (NASDAQ:NMRA).
Belite Bio has a consensus price target of $50.50.
The stock price for Belite Bio (NASDAQ: BLTE) is $47.97 last updated August 29, 2024 at 4:08 PM EDT.
There are no upcoming dividends for Belite Bio.
Belite Bio’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Belite Bio.
Belite Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.